New research published in Cancer Discovery, the newest journal of the American Association for Cancer Research, details a large-scale project in genetic profiling that has identified many of the weak points in breast tumor cells.
Alan Ashworth, Ph.D., chief executive officer of the Institute of Cancer Research in London, said the quest for a more personalized approach in cancer treatment has driven him and his colleagues to identify those genes upon which breast tumor cells are completely dependent. Ashworth and his colleague Christopher Lord, Ph.D., see this project as the first step toward the development of better treatments for the disease.
The American Association for Cancer Research hosted a teleconference on these findings on Tuesday, Aug. 2, 2011, at 10:00 a.m. ET. Read the press release for more information.
Listen to a recording of the teleconference:
Download* the mp3 of the teleconference (30.2 MB, 32 minutes and 56 seconds)
*On a PC, right mouse click on the "Download" link and select "Save link as..." in Firefox or "Save Target as..." in Internet Explorer.